-
Bristol Myers Squibb Announces Opdivo® Plus Chemotherapy as the First and Only Neoadjuvant-Only Immuno-Oncology Therapy to Demonstrate Statistically Significant and Clinically Meaningful Overall Survival in Resectable Non-Small Cell Lung Cancer
19 Feb 2025 12:09 GMT
… positive) non-small cell lung cancer (NSCLC).
OPDIVO® (nivolumab … with a fluoropyrimidine, oxaliplatin, and irinotecan. This … metastatic non-small cell lung cancer, in combination with … cell lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
-
Enhanced Antitumor Efficacy and Reduced Toxicity in Colorectal Cancer Using a Novel Multifunctional Rg3- Targeting Nanosystem Encapsulated with Oxaliplatin and Calcium Peroxide
24 Jan 2025 10:21 GMT
… amplify autophagy to assist oxaliplatin chemotherapy against colorectal cancer … Ginsenoside Rg3 sensitizes hypoxic lung cancer cells to cisplatin via … cisplatin resistance in lung cancer by downregulating PD- … advanced non-small cell lung cancer in China: a …
-
Drug-Eluting Beads Bronchial Arterial Chemoembolization Combined with Immunotherapy Resulted in Pathological Complete Response of Squamous Cell Lung Cancer: A Case Report
18 Dec 2024 16:06 GMT
… doxorubicin, pirarubicin, irinotecan, oxaliplatin, cisplatin, gemcitabine, etc … drug for treating lung cancer. Importantly, epirubicin … arterial chemoembolization in lung cancer patients with hemoptysis … pathologic assessment of lung cancer resection specimens …
-
Banner Year for Bispecifics as Therapies Advance Into the Community Setting
20 Feb 2025 02:11 GMT
… treated non–small cell lung cancer and pancreatic adenocarcinoma … non–small cell lung cancer. Beyond lung cancer, phase 2 data … for non-small cell lung cancer and pancreatic adenocarcinoma. FDA … glofitamab.plus.gemcitabine.and.oxaliplatin.28glofit-gemox29.for. …
-
Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations in Early and Advanced Stages of Non-Small Cell Lung Cancer
03 Jun 2024 12:19 GMT
… to biomarkers.
About Lung Cancer
Lung cancer is the leading cause … positive) non-small cell lung cancer (NSCLC).
OPDIVO® (nivolumab … with a fluoropyrimidine, oxaliplatin, and irinotecan. This … lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
-
Acidic Environment-Responsive Metal Organic Framework-Mediated Dihydroartemisinin Delivery for Triggering Production of Reactive Oxygen Species in Drug-Resistant Lung Cancer
29 Apr 2024 13:13 GMT
… and targeted treatments for lung cancer by harnessing the … biological bombs for efficient lung cancer therapy. J Colloid … KEAP1-NRF2 signaling in lung cancer: intertwined metabolic and … ROS-dependent apoptosis in oxaliplatin-resistant colorectal cancer …
-
Bristol Myers Squibb Provides Update on Phase 3 RELATIVITY-098 Trial
13 Feb 2025 21:41 GMT
… in non-small cell lung cancer.”
In adjuvant melanoma, Opdivo … positive) non-small cell lung cancer (NSCLC).
OPDIVO® (nivolumab … treatment with a fluoropyrimidine, oxaliplatin, and irinotecan. This … positive) non-small cell lung cancer (NSCLC).
OPDIVO QVANTIG™ …
-
Bristol Myers Squibb Announces Acceptance of U.S. and EU Regulatory Filings for Neoadjuvant Opdivo (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Opdivo in Resectable Non-Small Cell Lung Cancer
07 Feb 2024 12:27 GMT
… cancers to date, including lung cancer, bladder cancer, esophageal … response (MPR).
About Lung Cancer
Lung cancer is the leading … with a fluoropyrimidine, oxaliplatin, and irinotecan. This … lung cancer; Checkmate 816-neoadjuvant non-small cell lung cancer, …
-
Mini Review On: The Roles of DNA Nanomaterials in Phototherapy
13 Feb 2025 19:46 GMT
… cells. (B) The chemotherapeutic agent oxaliplatin (OXA) is encapsulated within the … al. Photodynamic therapy (PDT) for lung cancers. J Thoracic Oncol. 2006;1 …
-
Explaining KRAS Mutations For Patients With Colorectal Cancer
11 Feb 2025 21:58 GMT
… adults who previously received fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, according … other tumor types, such as lung cancer, where it is also approved …
About
© 1995-2025